189 related articles for article (PubMed ID: 37346980)
1. Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors.
Williams JA; Paez PA
Mol Ther Nucleic Acids; 2023 Jun; 32():494-503. PubMed ID: 37346980
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors.
Seyed N; Zahedifard F; Habibzadeh S; Yousefi R; Lajevardi MS; Gholami E; Rafati S
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298575
[TBL] [Abstract][Full Text] [Related]
3. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA.
Tolmachov OE
Med Hypotheses; 2010 Apr; 74(4):702-4. PubMed ID: 19914006
[TBL] [Abstract][Full Text] [Related]
4. DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations.
Schnödt M; Schmeer M; Kracher B; Krüsemann C; Espinosa LE; Grünert A; Fuchsluger T; Rischmüller A; Schleef M; Büning H
Mol Ther Nucleic Acids; 2016; 5(8):e355. PubMed ID: 28131313
[TBL] [Abstract][Full Text] [Related]
5. Suicide nanoplasmids coding for ribosome-inactivating proteins.
Mitdank H; Tröger M; Sonntag A; Shirazi NA; Woith E; Fuchs H; Kobelt D; Walther W; Weng A
Eur J Pharm Sci; 2022 Mar; 170():106107. PubMed ID: 34958884
[TBL] [Abstract][Full Text] [Related]
6. Cre-Mediated Transgene Integration in Chinese Hamster Ovary Cells Using Minicircle DNA Vectors.
Wang X; Kawabe Y; Hada T; Ito A; Kamihira M
Biotechnol J; 2018 Jul; 13(7):e1800063. PubMed ID: 29701326
[TBL] [Abstract][Full Text] [Related]
7. A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro.
Lu J; Zhang F; Kay MA
Mol Ther; 2013 May; 21(5):954-63. PubMed ID: 23459514
[TBL] [Abstract][Full Text] [Related]
8. Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus.
Suschak JJ; Dupuy LC; Shoemaker CJ; Six C; Kwilas SA; Spik KW; Williams JA; Schmaljohn CS
Mol Ther Methods Clin Dev; 2020 Jun; 17():810-821. PubMed ID: 32296729
[TBL] [Abstract][Full Text] [Related]
9. Minimized antibiotic-free plasmid vector for gene therapy utilizing a new toxin-antitoxin system.
Chen Z; Yao J; Zhang P; Wang P; Ni S; Liu T; Zhao Y; Tang K; Sun Y; Qian Q; Wang X
Metab Eng; 2023 Sep; 79():86-96. PubMed ID: 37451534
[TBL] [Abstract][Full Text] [Related]
10. Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial production yields.
Carnes AE; Luke JM; Vincent JM; Anderson S; Schukar A; Hodgson CP; Williams JA
J Gene Med; 2010 Oct; 12(10):818-31. PubMed ID: 20806425
[TBL] [Abstract][Full Text] [Related]
11. Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography.
Mayrhofer P; Blaesen M; Schleef M; Jechlinger W
J Gene Med; 2008 Nov; 10(11):1253-69. PubMed ID: 18767031
[TBL] [Abstract][Full Text] [Related]
12. A 5' Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors in vivo.
Lu J; Williams JA; Luke J; Zhang F; Chu K; Kay MA
Hum Gene Ther; 2017 Jan; 28(1):125-134. PubMed ID: 27903072
[TBL] [Abstract][Full Text] [Related]
13. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
Elife; 2021 Oct; 10():. PubMed ID: 34664552
[TBL] [Abstract][Full Text] [Related]
14. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
15. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
[TBL] [Abstract][Full Text] [Related]
16. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
Grimm D; Kay MA; Kleinschmidt JA
Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
[TBL] [Abstract][Full Text] [Related]
17. An advanced method for the small-scale production of high-quality minicircle DNA.
Mitdank H; Sama S; Tröger M; Testa MF; Ferrarese M; Balestra D; Pinotti M; Weng A
Int J Pharm; 2021 Aug; 605():120830. PubMed ID: 34214654
[TBL] [Abstract][Full Text] [Related]
18.
Lau CH; Suh Y
F1000Res; 2017; 6():2153. PubMed ID: 29333255
[TBL] [Abstract][Full Text] [Related]
19. Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.
Balke-Want H; Keerthi V; Gkitsas N; Mancini AG; Kurgan GL; Fowler C; Xu P; Liu X; Asano K; Patel S; Fisher CJ; Brown AK; Tunuguntla RH; Patel S; Sotillo E; Mackall CL; Feldman SA
Mol Cancer; 2023 Jun; 22(1):100. PubMed ID: 37365642
[TBL] [Abstract][Full Text] [Related]
20. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.
Chen ZY; He CY; Kay MA
Hum Gene Ther; 2005 Jan; 16(1):126-31. PubMed ID: 15703495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
